PROCEPT BioRobotics Corporation Lease, Cost
PROCEPT BioRobotics Corporation (PRCT) reported Lease, Cost of $6.61 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-26
- PROCEPT BioRobotics Corporation lease, cost for fiscal 2025 was $6.61M, a 6.79% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation lease, cost for fiscal 2024 was $7.09M, a 15.62% decline from fiscal 2023.
- PROCEPT BioRobotics Corporation lease, cost for fiscal 2023 was $8.40M, a 64.71% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation lease, cost for fiscal 2022 was $5.10M.
| Period end | Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $6.61M 10-K · filed 2026-02-26 |
| 2024-12-31 | $7.09M 10-K · filed 2026-02-26 |
| 2023-12-31 | $8.40M 10-K · filed 2026-02-26 |
| 2022-12-31 | $5.10M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |